Kirill Sharshov

Dr. Kirill Sharshov

Research Institute of Experimental and Clinical Medicine FRC FTM, Novosibirsk, Russia

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2010 in Emerging Infectious Diseases
Verified
Journal Article
Open access
KSKirill Sharshov
Kirill Sharshov
NSNikita Silko
Nikita Silko
ISIvan Sousloparov
Ivan Sousloparov
АЗАнна Владимировна Зайковская
Анна Владимировна Зайковская
ASAlexander M. Shestopalov
Alexander M. Shestopalov
IDIlia Drozdov
Ilia Drozdov

1 July 2016 in Journal of Basic Microbiology
Verified
Journal Article
Closed access
PDF file
WWWen Wang
Wen Wang
SZSisi Zheng
Sisi Zheng
KSKirill Sharshov
Kirill Sharshov
JCJian Cao
Jian Cao
HSHao Sun
Hao Sun
LLLaixing Li
Laixing Li

1 November 2019 in Emerging Infectious Diseases
Verified
Journal Article
Open access
PDF file
HZHong Zhou
Hong Zhou
Zhenghai MaZhenghai Ma
Zhenghai Ma
THTao Hu
Tao Hu
YBYuhai Bi
Yuhai Bi
AMAmutikari Mamuti
Amutikari Mamuti
WSWei-Feng Shi
Wei-Feng Shi
We isolated Tamdy virus (TAMV; strain XJ01/TAMV/China/2018) from Hyalomma asiaticum ticks infesting Bactrian camels in Xinjiang, China, in 2018. The genome of the strain showed high nucleotide similarity with previously described TAMV strains from Asia. Our study highlights the potential threat of TAMV to public health in China.

9 April 2023 in Viruses
Verified
Journal Article
Open access
PDF file
OKOlga Kurskaya
Olga Kurskaya
Elena ProkopyevaElena Prokopyeva
Elena Prokopyeva
ISIvan Sobolev
Ivan Sobolev
MSMariya V. Solomatina
Mariya V. Solomatina
TSTereza Saroyan
Tereza Saroyan
KSKirill Sharshov
Kirill Sharshov
A wide range of human respiratory viruses are known that may cause acute respiratory infections (ARIs), such as influenza A and B viruses (HIFV), respiratory syncytial virus (HRSV), coronavirus (HCoV), parainfluenza virus (HPIV), metapneumovirus (HMPV), rhinovirus (HRV), adenovirus (HAdV), bocavirus (HBoV), and others. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the COronaVIrus Disease (COVID) that lead to pandemic in 2019 and significantly impacted on the circulation of ARIs. The aim of this study was to analyze the changes in the epidemic patterns of common respiratory viruses among children and adolescents hospitalized with ARIs in hospitals in Novosibirsk, Russia, from November 2019 to April 2022. During 2019 and 2022, nasal and throat swabs were taken from a total of 3190 hospitalized patients 0–17 years old for testing for HIFV, HRSV, HCoV, HPIV, HMPV, HRV, HAdV, HBoV, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by real-time PCR. The SARS-CoV-2 virus dramatically influenced the etiology of acute respiratory infections among children and adolescents between 2019 and 2022. We observed dramatic changes in the prevalence of major respiratory viruses over three epidemic research seasons: HIFV, HRSV, and HPIV mainly circulated in 2019–2020; HMPV, HRV, and HCoV dominated in 2020–2021; and HRSV, SARS-CoV-2, HIFV, and HRV were the most numerous agents in 2021–2022. Interesting to note was the absence of HIFV and a significant reduction in HRSV during the 2020–2021 period, while HMPV was absent and there was a significant reduction of HCoV during the following epidemic period in 2021–2022. Viral co-infection was significantly more frequently detected in the 2020–2021 period compared with the other two epidemic seasons. Certain respiratory viruses, HCoV, HPIV, HBoV, HRV, and HAdV, were registered most often in co-infections. This cohort study has revealed that during the pre-pandemic and pandemic periods, there were dramatic fluctuations in common respiratory viruses registered among hospitalized patients 0–17 years old. The most dominant virus in each research period differed: HIFV in 2019–2020, HMPV in 2020–2021, and HRSV in 2021–2022. Virus–virus interaction was found to be possible between SARS-CoV-2 and HRV, HRSV, HAdV, HMPV, and HPIV. An increase in the incidence of COVID-19 was noted only during the third epidemic season (January to March 2022).

16 October 2019 in Viruses
Verified
Journal Article
Open access
PDF file
Denis KorneevDenis Korneev
Denis Korneev
OKOlga Kurskaya
Olga Kurskaya
KSKirill Sharshov
Kirill Sharshov
JEJustin Eastwood
Justin Eastwood
Marina StrakhovskayaMarina Strakhovskaya
Marina Strakhovskaya
Ultrastructural studies revealing morphological differences between intact and photodynamically inactivated virions can point to inactivation mechanisms and molecular targets. Using influenza as a model system, we show that photodynamic virus inactivation is possible without total virion destruction. Indeed, irradiation with a relatively low concentration of the photosensitizer (octacationic octakis(cholinyl) zinc phthalocyanine) inactivated viral particles (the virus titer was determined in Madin Darby Canine Kidney (MDCK) cells) but did not destroy them. Transmission electron microscopy (TEM) revealed that virion membranes kept structural integrity but lost their surface glycoproteins. Such structures are known as “bald” virions, which were first described as a result of protease treatment. At a higher photosensitizer concentration, the lipid membranes were also destroyed. Therefore, photodynamic inactivation of influenza virus initially results from surface protein removal, followed by complete virion destruction. This study suggests that photodynamic treatment can be used to manufacture “bald” virions for experimental purposes. Photodynamic inactivation is based on the production of reactive oxygen species which attack and destroy biomolecules. Thus, the results of this study can potentially apply to other enveloped viruses and sources of singlet oxygen.

1 September 2012 in Avian Diseases
Verified
Journal Article
Closed access
MSMariya Sivay
Mariya Sivay
SSSofya G. Sayfutdinova
Sofya G. Sayfutdinova
KSKirill Sharshov
Kirill Sharshov
AAAlexander Yurievich Alekseev
Alexander Yurievich Alekseev
AYAleksander K. Yurlov
Aleksander K. Yurlov
ASAlexander M. Shestopalov
Alexander M. Shestopalov
Wild waterfowl undertake a variety of long-distance flights during their migration. These flights provide birds with the opportunities to both acquire and disseminate avian influenza viruses (AIVs). The Asian portion of Russia is crossed by four major migration routes and represents the major breeding area for many wild bird species in the Palearctic. The Asian territory of Russia plays an important role in distribution, persistence, and evolution of AIVs due to the ecologic relationships of bird populations from Russia and different Asian, European, African, and North American countries. Our study highlights the results of surveillance conducted in 2008 for AIVs in wild birds in the Asian portion of Russia. During this study, our team collected and tested 5678 samples from wild birds. Among them, 41 samples tested positive for AIV with an isolation rate of 0.72%. The highest AIV prevalence, 1.49%, was found in Anseriformes. In Ardeidae and Laridae, the AIV prevalence was 1.23% and 0.64%, respectively. Rallidae showed the lowest AIV prevalence of 0.61%. Phylogenetic analysis of H3 and H4 subtypes represented close relationships of AIVs isolated from the Asian portion of Russia to the AI strains from Asia, Africa, and Europe. These findings were confirmed by the wild bird migration routes that affect bird populations from Eurasian, African, Australian, and North American continents.